Exosome Diagnostics To Present Data At The 26th AACR-National Cancer Institute-EORTC International Conference On Molecular Targets And Cancer Therapeutics
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exosome Diagnostics, Inc., a developer of revolutionary, biofluid-based molecular diagnostics, announced that the company will present two posters at the 26th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, taking place November 5-9 at the Hynes Convention Center in Boston, Mass.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.